Clozapine in the treatment of refractory psychotic mania

American Journal of Psychiatry

Volumn 157, Issue 6, 2000, Pages 982-986

  Green, Alan I ^a   Tohen, Maricio ^b   Patel, Jayendra K ^b   Banov, Michael ^b   DuRand, Curtiss ^b   Berman, Ileana ^b   Chang, Howard ^b   Zarate Jr , Carlos ^b   Posener, Joel ^b   Lee, Hang ^b   Dawson, Ree ^b   Richards, Carol ^b   Cole, Jonathan O ^b   Schatzberg, Alan F ^b  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PATIENT DROPOUTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SEX FACTORS; TREATMENT OUTCOME;

EID: 12944286545     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.6.982     Document Type: Article

References (27)

1. Marder SR, Van Putten T: Who should receive clozapine? Arch Gen Psychiatry 1988; 45:865-867
2. Green AI, Salzman C: Clozapine: benefits and risks. Hosp Community Psychiatry 1990; 41:379-380
3. Baldessarini RJ, Frankenburg FR: Clozapine: a novel antipsychotic agent. N Engl J Med 1991; 324:746-754
4. Owen RR Jr, Beake BJ, Marby D, Dessain EC, Cole JO: Response to clozapine in chronic psychotic patients. Psychopharmacol Bull 1989; 25:253-256
5. Naber D, Hippius H: The European experience with use of clozapine. Hosp Community Psychiatry 1990; 41:886-890
6. McElroy SL, Dessain EC, Pope HG Jr, Cole JO, Keck PE Jr, Frankenburg FR, Aizley HG, O'Brien S: Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991; 52:411-414
7. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO: Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992; 32: 270-280
8. Banov MD, Zarate CA Jr, Tonen M, Scialabba D, Wines JD Jr, Kolbrener M, Kim JW, Cole JO: Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994; 55:295-300
9. Zarate CA Jr, Tohen M, Banov MD, Weiss MK, Cole JO: Is clozapinea mood stabilizer? J Clin Psychiatry 1995; 56:108-112
10. Zarate CA Jr, Tohen M, Baldessarini RJ: Clozapine in severe mood disorders. J Clin Psychiatry 1995; 56:411-417
11. Calabrese JR, Meltzer HY, Markovitz PJ: Clozapine prophylaxis in rapid cycling bipolar disorder J Clin Psychopharmacol 1991; 11:396-397
12. Frankenburg FR: Clozapine and bipolar disorder. J Clin Psychopharmacol 1993; 13:289-290
13. Kimmel SE, Calabrese JR, Woyshville MJ, Meltzer HY: Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994; 55(suppl B):91-93
14. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY: Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153:759-764
15. Lukoff D, Nuechterlein KH, Ventura J: Appendix A: manual for Expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull 1986; 12:594-602
16. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 218-222
17. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York, New York State Psychiatric Institute, Biometrics Research, 1988
18. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
19. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982; 38:963-974
20. Strous RD, Patel JK, Green AI: Clozapine in the treatment of refractory mania. Essential Psychopharmacology 1998; 2:385-402
21. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V (Olanzapine HGEH Study Group): Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156:702-709
22. Lieberman JA, Kane JM, Safferman AZ, Pollack S, Howard A, Szymanski S, Masiar SJ, Kronig MH, Cooper T, Novacenko H: Predictors of response to clozapine. J Clin Psychiatry 1994; 55(suppl B):126-128
23. Parsa MA, Ramirez LF, Loula EC, Meltzer HY: Effect of clozapine on psychotic depression and parkinsonism. J Clin Psychopharmacol 1991; 11:330-331
24. Dassa D, Kaladjian A, Azorin JM, Giudicelli S: Clozapine in the treatment of psychotic refractory depression. Br J Psychiatry 1993; 163:822-824
25. Privitera MR, Lamberti JS, Maharaj K: Clozapine in a bipolar depressed patient (letter). Am J Psychiatry 1993; 150:986
26. Ranjan R, Meltzer HY: Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 1996; 40:253-258
27. Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ: Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156:1164-1169